Tags Posts tagged with "cannabis stock news"

cannabis stock news

0 351

The Dea’s acting Chief Chuck Rosenberg reiterated an Obama-era stance this past Thursday that “marijuana is not medicine.

“If it turns out that there is something in smoked marijuana that helps people, that’s awesome,” he said, speaking at the Cleveland Clinic in Ohio. “I will be the last person to stand in the way of that. … But let’s run it through the Food and Drug Administration process, and let’s stick to the science on it.”

Marijuana is classified as a Schedule I drug under the Controlled Substances Act, alongside drugs like heroin and LSD, while other substances like oxycodone and methamphetamine are classified as Schedule II drugs, which are regulated differently. Despite repeated attempts by advocates requesting that marijuana be moved to Schedule II, the DEA has pointed to the FDA’s guidance that says it does not have medical value.

Chuck Rosenberg Doesn’t Believe That Marijuana Is Medicine

Rosenberg highlighted that the DEA takes recommendations about how to classify the drug from the FDA. He pointed out that marijuana studies have been ongoing and acknowledged some studies show it may have medical benefits for children with epilepsy.

Former Surgeon General Vivek Murthy, who was speaking alongside Rosenberg at the event, said that the country should be researching medical marijuana.

“Should we be reducing the administrative and other barriers to researching that in the government? 100 percent,” he said. “But what we should not do is make policies based on guesswork. When we do that, what we do is put people at risk.”

He also appeared to show some concern around state laws regarding recreational marijuana, saying that it is addictive, which can be harmful to a developing brain that is vulnerable to developing substance abuse and addiction. State legislators, he said, have gotten “caught up in momentum” and passed policies on recreational marijuana that aren’t always supported by science.

“When you develop a substance use disorder at a young age, it actually increases the likelihood of you developing an addiction to other substances,” he said. “So in that sense addiction to marijuana or any substance, including nicotine, during adolescence and young adulthood when the brain is developing is very concerning.”

“I worry that we have gotten away from allowing science to drive our policy when it comes to marijuana,” he added.

0 306

Cannabis Science, Inc. Receives U.S. Federal Government Clearance to Receive U.S. Federal Government Contracts

Cannabis Science has completed its registration in the U.S. Government’s System for Award Management (SAM), and has applied for and received a Commercial and Government Entity (CAGE) Code from the Defense Logistics Agency’s CAGE Program Office at the U.S. Department of Defense. Cannabis Science is now listed with all U.S. companies eligible for Federal Government Contracts. “Achieving eligibility to access contracting opportunities with the U.S. Federal Government is a significant step for Cannabis Science,” stated Mr. Raymond C. Dabney, Cannabis Science’s President, CEO, and Co-founder. “I believe we can leverage the unique experience and expertise of our company to win new business and grow Cannabis Science’s revenue base. We also plan to work closely with our strategic partners and collaborators to access Federal contracting and grant opportunities.”

Cannabis Science is registered in SAM with three North American Industry Classification System (NAICS) Codes:

§ 541711 – Research and Development In Biotechnology
§ 621511 – Medical Laboratories
§ 624230 – Emergency and Other Relief Services

SAM is the primary vendor database for the U.S. Federal Government. Having vendor information immediately available allows the U.S. Government to rapidly find the companies with the right capabilities to offer services for required government contracts, government initiatives, research & development projects, and particular supply needs, as well as for pandemic alert and other emergency requirements.

Cannabis Science intends to explore funding opportunities, individually and with its collaborators, with institutions such as the National Institutes of Health (NIH), institutes within NIH, such as the National Institute on Drug Abuse (NIDA), and others.

As part of its mandate to study drug abuse and addiction and other health effects of both legal and illegal drugs, NIDA funds a wide range of research on marijuana (cannabis); its main psychotropic ingredient, delta-9-tetrahydrocannabinol (THC); and chemicals related to THC (cannabinoids). Research suggests that THC and other cannabinoids may have potential in the treatment of pain, nausea, epilepsy, obesity, wasting disease, addiction, autoimmune disorders, and other conditions. NIDA has provided and continues to provide funding for research related to therapeutic uses of cannabinoids as it pertains to its mission, including studies on the use of THC and cannabidiol (CBD), another chemical constituent of marijuana, for the treatment of pain (as an alternative to opioid pain relievers), addiction, and other disorders. Research on therapeutic uses of marijuana or of specific chemicals in the marijuana plant for other diseases and conditions is supported by other components of NIH as is appropriate to their mission. For a complete listing of all projects funded by NIH examining the potential therapeutic benefits of cannabinoids, see the Therapeutic Cannabinoid Research category in the NIH Report database.

The vast majority of research proposals received and funded by NIH on therapeutic benefits of cannabinoids have examined individual cannabinoid chemicals or, in a few cases, marijuana leaves delivered through some means other than smoking. Research proposals submitted to any NIH Institute of Center (IC) to study therapeutic benefits of marijuana or one of its ingredients must meet the same accepted standards of scientific design as any other proposal and, on the basis of peer review, should meet public health significance and IC priorities to be competitive with other applications that qualify for funding. NIDA is a scientific, not a policy-making agency. The same is true for the NIH as a whole. NIDA’s role is to conduct and support scientific research on drugs and drug abuse and to advise the public and policy-makers, such as Congress, the White House Office of the National Drug Control Policy, and the U.S. Drug Enforcement Administration on the results of that research — with the goal of ensuring that the nation’s drug policies are informed by science. That said, NIDA does closely watch legislative changes both nationally and at the state level and supports research that studies how changing drug policies — for instance laws around recreational or therapeutic use of marijuana — affect rates of substance use and related public health issues.

0 721

The state of South Carolina’s General Assembly recently legalized the farming of industrial hemp. As local newspapers quickly clarified the difference between hemp and its more popular relative marijuana, state politicians and farmers jumped for joy.

“Any agricultural crop we can cultivate here and make a profit for our farmers, we should try,” said Republican State Senator Greg Hembree.

After all, agribusiness is the No. 1 industry in the Palmetto State, so farmers are also celebrating.

South Carolina really needed this

South Carolina farmer Neal Baxley, confirmed that he is definitely interested in planting hemp on some of his available fields where “sunshine is frequent and rain is regular.”

“We’re in an economically depressed region of the state,” said Baxley “So why couldn’t South Carolina attract a new industry, something that has some growth potential? The more people who get the opportunity to get involved in agriculture, the better I think we are in the long run.”

Democratic Representative Russell Ott, co-sponsor of the bipartisan Hemp Bill, said he wouldn’t be surprised if farmers are growing hemp in the next few months.

“The bottom line is, we could have hemp being grown in South Carolina this year. And that’s exciting,” said Ott, who is also a farmer.

People are expecting South Carolina’s authorities to issue at least 20 licenses to grow crops on up to 20 acres as a pilot program, with more to be added soon.

“It’s my hope that they will act very quickly,” said State Sen. Danny Verdin, chairman of the Senate Agriculture and Natural Resources Committee.

Today, about 90 percent of the hemp used in the United States for industrial purposes is imported from China. But, it’s time to bring it back home.

One of the fastest-growing plants in the world and known as the most versatile plant on earth, hemp is used for making all manner of essential objects such as paper, textiles, cloth, biodegradable plastics, paint, biofuel—the list is long.

But, because it is part of the marijuana plant, it was declared illegal in the U.S. in 1937. The industry is just barely getting back in on its feet again, thanks to the 2014 farm bill passed under President Obama.

One of the problems about sanctioning hemp cultivation has been due to the spread of a spurious lie that large hemp fields could be used to mask weed cultivation. John Finamore, executive director of the National Hemp Association in Denver, shot that notion down.

“The last thing a marijuana grower wants to do is grow them together,” he stated, noting that hemp is the dominant of the two species and would neutralize the psychoactive compounds in marijuana.

And no one wants that.

0 166

Future Farm to Launch “Hamptons Reserve” A New Luxury Cannabis Brand

Future Farm will leverage its existing high quality cannabis oils and flower products to develop an extensive product line comprised of THC and CBD infused products, including gummies, chocolate bars and other products that will be marketed under the exclusive Hamptons Reserve brand. The Company also acquired the right to sublicense the Hamptons Reserve brand worldwide.

“We are excited to add this unique, recognizable upscale brand as part of our product offering,” said Bill Gildea, Future Farm’s CEO. “With the Hamptons Reserve brand, we will instantly be able to command the attention of cannabis enthusiasts looking for the highest quality edibles, while at the same time opening the door to licensing revenue.”

The Hampton Chocolate Factory, LLC has established itself as the premiere chocolate company in the Hamptons, which embodies upscale quality and taste. It has two locations, including the original in Hampton town, Westhampton Beach, NY, and another in the North Fork foodie destination of Greenport, NY.

“As a resident of the Hamptons, I am excited to export our luxury chocolate brand outside of Long Island so it can take its rightful place among the biggest and most recognizable brands,” comments Evan Gappelberg, CEO of The Hampton Chocolate Factory. “The development of Hampton Reserves accelerates our plans to expand The Hampton Chocolate Factory brand globally.”

For further information, contact William Gildea, Director, at 617.834.9467.

On behalf of the Board,

Future Farm Technologies, Inc.

William Gildea, Chairman & CEO

About Future Farm

The Company’s business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generate yields up to 10 times greater per square foot of land. The contained system provides many other benefits including seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability.

The Company is also in the business of designing and distributing LED lighting solutions utilizing the COB and MCOB technology. The Company is focused on delivering cost efficient lighting to North America via advanced e-commerce sites the Company owns and operates. LEDCanada.com which caters to B2B customers is a supplier of the newest and highest demand LED solutions. The Company also owns and operates COBGrowlights.com which caters to both large and small agriculture green houses and controlled cultivation centers.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. 

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

0 203

FBEC Worldwide, Inc. to Sponsor Star-Studded Music Festival This Weekend, May 27 – May 28

Ship Show is a two (2) day music festival beginning Saturday, May 27, 2017 & concluding Sunday, May 28, 2017. Ship Show will take place on the deck of the USS Hornet Air Craft Carrier located at 707 W Hornet Ave, Alameda, CA 94501. The star-studded artist lineup includes:

  • Wiz Khalifa
  • Wu-Tang Clan
  • Lupe Fiasco
  • YG
  • Jeremih
  • DJ Mustard
  • DMX
  • Wyclef Jean
  • Plus, Many More

The full artist lineup & tickets can be found at http://ship-show.com/

CEO Jeff Greene stated, “We are excited to present our newly re-formulated & re-branded Healthy Hemp Energy Shot to the masses at Ship Show.”

FBEC has provided the event with 6,000 bottles of its newly re-formulated & re-branded Healthy Hemp Energy Shot, to be distributed during the event.

About FBEC Worldwide, Inc.

FBEC Worldwide, Inc. is a lifestyle Brand Company with a focus on Healthy Hemp Energy & CBD infused consumer products, both domestic and abroad. We are committed to increasing our market size and scope through the optics of creative marketing and most importantly customer satisfaction. Our growth strategies focus on several major initiatives, including unique branding opportunities that will be targeted at key demographic groups and to develop strong community and distributor relationships.

FBEC Worldwide is currently developing and building Healthy Hemp & CBD infused consumer products, focused on strong rates of growth within key fundamental consumer groups. Our company is dedicated to becoming the lead developer of name brand hemp & CBD infused consumer products.

Website: http://HealthyHempEnergy.com
Facebook: https://www.facebook.com/healthyhempenergy/
Twitter: https://twitter.com/hh2energy

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.

Investor Relations Contact:

0 304

Rocky Mountain High Brands Announces Indian Nation Wholesale Adds Eagle Spirit Spring Water to Its Product Line – Distribution Agreement Signed for Oklahoma, Texas, Missouri, Kansas and Arkansas

 Rocky Mountain High Brands, Inc. (RMHB), a fully reporting consumer goods company specializing in hemp-infused food and beverage products and a naturally high alkaline water, announced today that a distribution agreement with Stephenson Wholesale Co., Inc., dba Indian Nation Wholesale, was recently signed.  As a result, Eagle Spirit Spring Water will be added to their product line as a premium water.

Michael Welch, President and Chief Executive Officer of Rocky Mountain High Brands, stated, “Indian Nation Wholesale chose Eagle Spirit Spring Water as a premium water after an extensive evaluation process.  They loved the story of our water and its Native American heritage.  Our Made/Produced by American Indians certification mark also was another contributing factor in their decision. It provided our Rocky Mountain High Water Company subsidiary the needed authenticity of being a Native American Majority Owned Enterprise. The taste of our water, its story, its Native American Heritage and the Made/Produced by American Indians certification mark will all be huge selling tools for Indian Nation Wholesale’s staff when they call on their customers, which include casinos located in Southern Oklahoma.”

Welch continued, “Indian Nation Wholesale is a highly respected and experienced distributor and has a very strong footprint in market growth areas that are closer to our corporate headquarters in Dallas. This marketing strategy perfectly aligns itself with the recommendations from our new Board members, Gerry David and Kevin Harrington. Our agreement with Indian Nation Wholesale is the first of many steps toward achieving that commitment to Mr. David and Mr. Harrington in growing the market in our own back yard.”

About Indian Nation Wholesale:

Stephenson Wholesale Co., Inc., dba Indian Nation Wholesale (INW), was founded in 1953 and is the 19th largest distributor in the nation with over 8,000 products and 200,000 square feet of warehouse space. Indian Nation Wholesale has a truck fleet that provides regular delivery to over 2,500 accounts, including convenience stores, restaurants, institutional accounts, concessions, vending, casinos and gift shops. INW offers top industry products in a large variety of categories such as candy, beverage, snacks, HBA, foodservice, paper goods and much more.

Their warehouse utilizes state of the art technology including innovations from Vocollect, Tax Right and Red Stamp to increase our error-free delivery rate in excess of 99.6%. INW’s well-maintained fleet and courteous drivers stand ready to provide their customers with accurate, on-time next-day delivery, with no order minimums or tote charges. They have a host of value-added services such as store resets, shelf-tagging and the equipment for many areas in their customer’s store. Additionally, they support their retailers with opportunities through marketing programs, such as the GATEWAY CUSTOMER LOYALTY PROGRAM. INW now has over 300 employees at three locations; INW’s success has been built on service and customer satisfaction.
Learn more about Indian Nation Wholesale at: www.inwsupply.com

About Rocky Mountain High Brands:

ROCKY MOUNTAIN HIGH BRANDS, INC., is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots. The Company recently launched a naturally high alkaline spring water, Eagle Spirit Spring Water.

For interested investors, our stock symbol is RMHB.

For ordering information please visit: LiveRockyMountainHigh.com

For corporate information please visit: RockyMountainHighBrands.com

For information on our high alkaline water visit: EagleSpiritWater.com

For Rocky Mountain High Distribution Contact:

Chuck Smith (972) 955-0964

0 264

Greengro Technologies, Inc. Retains the Auditing Services of Notable Accounting Firm, M&K CPAS, PLLC

Greengro Technologies, Inc. (GRNH), a world-class provider of eco-friendly green technologies, is pleased to announce that the Company has retained the auditing services of M&K CPAS of Houston, Texas, a distinguished Full-Service CPA and business consulting firm, to fulfill the necessary requirements for up-listing to the OTCQB, in pursuit of heightened transparency and corporate advancement.

M&K CPAS, PLLC is a distinguished full-service CPA firm that provides audit & assurance services, financial reporting, and fulfills the tax needs of growing micro and small-cap publicly traded companies domestically as well as globally. As a registered Accounting firm with the Public Company Accounting Oversight Board, the firm brings reliable, top-quality expertise to the table.  Greengro’s plan is to meet standards to up-list to OTCQB, filing a Form S-1 and become fully reporting.

James Haas, CEO of Greengro Technologies, Inc. stated: “We are very pleased with the team that we have brought on board to assist us in this undertaking. It’s of upmost importance that we engage the full support of highly respected professionals, who have acquired the expertise to help us organize and fulfill the listing requirements to achieve an elevated tier, in preparation for our ultimate aspiration of up-listing to the Small Cap NASDAQ Capital Market.”

Greengro Technologies recently disclosed that the Company had accomplished a substantial over 100% boost in revenues year over year. With record breaking results reflecting exponential growth and the establishment of funding necessary to facilitate the build out of two Marijuana igot420 Dispensaries in California, North Hollywood and Cathedral City, the Company prepares for continuing national expansion.

Haas concluded: “In reflection of our commitment to transparency, we trust that it is in the best interest of our investors to move up to the more distinguished OTCQB, where our Company will have greater visibility before a larger group of investors. We are excited to be advancing, and believe that our shareholders will greatly benefit from these efforts.”

As markets continue to open, creating evolving new industry demands, Management is keenly focused on the capitalization of congruent developing niches that seamlessly align with the Greengro’s core business model. The Company will keep shareholders updated as events unfold with the its new product line, as well as other projects currently underway.

About Greengro Technologies: Greengro Technologies (GRNH) is a world class provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, small and large scale commercial clients. Greengro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors.

The company’s websites: www.greengrotech.com, offer regular updates including educational videos, projects updates, recipes and nutritional information, and where to find the company’s products. https://www.facebook.com/GreengroTechnologiesInc/

Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company’s public announcements.

0 360

There’s a new star in Florida’s medical marijuana industry, and it’s got South Florida connections. This past Wednesday, a company associated with Canadian cannabis operator Aphria and an equity firm Delavaco Group stationed in Fort Lauderdale announced that it has closed on a deal to manage Chestnut Hill Tree Farm, one of seven medical marijuana farmers and distributors in the state.

The deal has been given a green light by the Florida Department of Health.

Under the arrangement, a company operating as Aphria USA will manage the operations of Chestnut Hill Tree Farm, a nursery that does business as CHT Medical. That includes the “cultivation, processing, and dispensing of medical marijuana to patients within the State of Florida” and “the exclusive benefits of the finances from Chestnut’s operation.”

Currently, CHT Medical delivers its medicine to patients. But Aphria plans to significantly increase the size of the company’s operations and establish a network of dispensaries around the state.

“Chestnut is one of a select few licensed producers serving a state with a population over 21 million people,” stated Aphria CEO Vic Neufeld. “It is only the beginning for our plans to be a dominant player in the medical cannabis industry internationally.”

The management agreement allows Delavaco and Aphria to enter into a relatively exclusive market at full force which is on the verge of growing following the November passage of a medical marijuana constitutional amendment. However, it comes at an uncertain time, and amid a flurry of investment and speculation.

The state’s medical marijuana program is about to expand, but as of yet, there are no rules to guide the system, as the Legislature failed to come up with any in its recent session. And it’s unclear whether the state will regulate the number of retail outlets its license-holders can open — a key sticking point that killed a bill this month.

It’s also unclear whether any new licenses will be awarded, although, on Tuesday, an administrative law judge recommended the state issue two new ones, an order the state says it’s still reviewing. Still, Aphria says it remains bullish on the Florida market.

0 527

Apart from increases in adult marijuana possession arrests in counties the border with legal states, a new working paper from the National Bureau of Economic Research has discovered that state marijuana legalization has little effect on neighboring states.

Why Do Legal Marijuana States Hold Little Impact On Neighboring Counties

In the paper, The Cross-Border Spillover Effects of Recreational Marijuana Legalization, professors Zhuang Hao and Benjamin Cowan from the School of Economic Sciences at Washington State University found that legalization “causes a sharp increase in marijuana possession arrests of border counties relative to non-border counties.”

“If a county shares a physical border with [a legalized] state,” the authors note, “it experiences an increase in marijuana possession arrests of roughly 30 percent.”

However, the study found that the increased arrests are almost entirely among adults.

“[Legalization] has no impact on juvenile marijuana possession arrests,” in reference to the information given, which also shows that there is no “evidence that marijuana sale/manufacture arrests… of border, counties are affected on net by [legalization].”

While the counties bordering a legalized state see an increase in adult arrests, the researchers found that the counties farther from the border experience a decline in adult possession arrests. Impaired driving statistics improved as well.

“DUI arrests decrease markedly for both border counties and non-border counties after [legalization],” the authors concluded.

Both authors professor Zhuang Hao and Benjamin Cowan presented caution that the increase in border county arrests can’t necessarily be tied to increased trafficking of marijuana across state lines. Following legalization, “police officers might adopt new techniques or use more resources toward cracking down on what they perceive to be more illegal marijuana possession.”

Professor Zhuang Hao and Benjamin Cowan couldn’t find an increase in employment of police officers in the bordering counties following marijuana legalization. In conclusion, the authors suggest that marijuana legalization could cause an increase in law enforcement and criminal justice costs for the neighboring states. Maybe those states would be better assisted by joining their neighbors in legalizing marijuana for adult use, thus saving those law enforcement costs and earning tax revenue to boot.

0 895

Tetra Bio-Pharma Signs Definitive Agreement for Two Products with Panag Pharma

Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), announced today it has signed a definitive agreement with Panag Pharma Inc. for the development and commercialization of novel cannabinoid based formulations for the treatment of pain and inflammation. Combined total market potential of both products in the USA in 2014 is estimated over US$5.5 billion. The recent press release on May 17th for the filing of a patent in ocular disease combined with the patents from Panag in the ocular space make this agreement very lucrative.

Per the definitive agreement, Tetra will have exclusive access to sell the ocular and topical drug products in North America with right of first negotiation for outside U.S. and Canadian territories. In addition, Tetra will have a right of first negotiation for future cannabinoid-based products.

Tetra will work in close collaboration with Panag’s team of experts to ensure a rapid and successful development leading to marketing authorization. Panag will continue work in the development of novel products for unmet medical need and Tetra will take the lead in commercializing these novel drug products.

“We are very pleased to announce this partnership with Panag as we work towards building an innovative product pipeline focused on cannabis,” said Andre Rancourt, CEO of Tetra Bio-Pharma. “Tetra is committed to generating revenues in 2017 by launching several products in the retail market through its partnership with Panag.”

Panag has developed potential new cannabinoid-based therapies for ocular and topical anti-inflammatory and pain markets. The total ocular anti-inflammatory market was estimated at over $3 billion in the USA in 2014 and includes conditions such as post-op inflammation, allergic conjunctivitis and inflammatory dry eye. Panag also developed a cannabinoid topical drug product for the local treatment of pain and inflammation. In 2014, the over the counter sales of topical analgesics were estimated at over $2.5 billion according to IMS.

“We will prioritize the development of the ocular therapy as this is a promising innovative product with high medical need and a significant potential financial reward,” said Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma. Tetra has positioned itself to become a leader in topical pain relief.

Corporate Update:

Tetra changed today at the opening of the U.S. markets its OTCQB stock symbol to TBPMF.

The Company issued 501,800 new shares as part as of a service agreement as previously announced in a news release on June 20, 2016.

The Company issued an additional 250,000 new shares as part of a service agreement with MAPH Enterprises, LLC, effective May 8, 2017 to broaden U.S. investor awareness.

About Panag Pharma:

Panag Pharma Inc. is a Canadian based bio-tech company focused on the development of novel cannabinoid based formulations for the treatment of pain and inflammation. Panag believes that pain relief should be safe, non-addictive and above all; effective. The Panag Pharma team of PhD scientists and medical doctors are among the world’s leading researchers and clinicians in the area of pain treatment and management. They bring a combined experience of over 100 years in research and clinical care of people dealing with chronic pain and inflammatory conditions. Panag’s current pipeline of pain relief products include formulations for the topical application to the skin, the eye and other mucous membranes. Recently approved by Health Canada and currently undergoing clinical trials, Panag Pharma’s Topical AOTC provides a new approach to the treatment of chronic pain and inflammation.

About Tetra Bio-Pharma:

Tetra Bio Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Source: Tetra Bio-Pharma Inc.


  • Tetra Bio-Pharma Inc.
    Edward Miller
    Vice President, IR & Corporate Communications
    (514) 360-8040 Ext. 203

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements